Our history

2011 marked the beginning of a company inspired by the concept of "One Health”. Founded by veterinary oncologist Dominique Tierny, OCRvet emerged with the clear goal of moving beyond the conventional wisdom of medicine and introducing innovative approaches to animal health.

R&D assets evolution

2011

  • Vet sites for comparative medicine
  • Project selected and funded by the French Inter-Ministry Fund : Caninca
2011

2014-2019

  • Comparative medicine in oncology for Pharma-Biotech (EU, US)
2014-2019

2016

  • DogToMan project selected and funded by the French Inter-Ministry Fund
  • European veterinary clinical network
  • Labcom “O’Dreams”: OCR/PRISM (Inserm Univ Lille)
2016

2019

  • Development of innovative tools to expand the canine model contribution in translational oncology : Eureka ICOM
2019

2021

  • Project on canine mammary tumor : 3R INCa
  • Development of a robot- assisted medical device for biopsy and brachytherapy of the prostate under MRI imaging control : CoBra
2021

2024

  • Biomedical innovation for facial bone reconstruction in oncology : BIOFACE
2024

Service offering evolution

2011

  • Creation of OCR – (Oncovet Clinical Research)
  • Biobank
2011

2014-2019

  • Development of a French veterinary clinical network
  • Lille’s ONCOLILLE consortium labelled Integrated Cancer Research Site
2014-2019

2016

  • Regulatory veterinary clinical trials
  • Consulting services in innovative veterinary products development (scientific, regulatory)
  • Histology / IHC preclinical
2016

2019

  • In vivo / ex vivo canine trials
  • Preclinical studies coordination
2019

2022

  • Launch in Poland
  • Recruitment of a veterinary clinical research assistant in Poland
2022

2023

  • New services in Data Management
  • Name changed to OCRvet
2023

2024

  • Launch in Italy and Portugal
  • New website
  • Target for ISO 9001 label
2024

Discover our different areas of research to support those who are shaping tomorrow's health solutions.

Scroll to Top